AIDS Vaccines, HIV Receptors, and AIDS Research. (Record no. 59560)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 07657nam a22004693i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC3018307 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729124057.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2008 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781608764808 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781606920749 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC3018307 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL3018307 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10660168 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)923657722 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | QR189.5.A33 -- A43 2008eb |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615/.372 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Kendow, Lawrence B. |
| 245 10 - TITLE STATEMENT | |
| Title | AIDS Vaccines, HIV Receptors, and AIDS Research. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | New York : |
| Name of producer, publisher, distributor, manufacturer | Nova Science Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2008. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2009. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (358 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- AIDS VACCINES, HIV RECEPTORS, AND AIDS RESEARCH -- CONTENTS -- PREFACE -- Chapter 1 SAFE AND EFFECTIVE HIV VACCINES SINCE 1999 -- ABSTRACT -- INTRODUCTION -- SOME PRE-1984 VACCINES FOR HUMAN USE -- Plague -- Variolation -- Edward Jenner's Smallpox Vaccine -- Louis Pasteur's Vaccines -- Polio Vaccines -- THE NORMAL HUMAN IMMUNE RESPONSE -- THE WORST PANDEMIC IN HISTORY, HIV/AIDS -- The First Announcement of the Isolation of the Causative Agent of AIDS -- The Natural History of HIV Infection in Man -- Ethical Considerations in HIV Preventive Vaccine Research -- THE AUTHOR'S APPROACH TO HIV VACCINES DEVELOPMENT -- A General Surgeon Involved with HIV Vaccines Research and Development? -- What is Cure of HIV Infection? -- The Stepping Stone for HIV Preventive Vaccines Development -- Not all Medical Remedies Require Registration before use on Patients -- Possible Appropriate Immunogens for a Candidate HIV Therapeutic Vaccine -- Confirmation of the Safety of the Candidate Autogenous HIV Therapeutic Vaccine -- Efficacy Trials of the Safe Candidate HIV Therapeutic Vaccine -- Proceeding to the HIV Preventive Vaccine -- Modifications to the Initial Vaccines and Dosage Regimen -- THE VACCINES ON LARGER POPULATIONS -- VEHEMENT RESISTANCE TO ATTEMPTS TO LOCK UP OUR HIV VACCINES -- CONCLUSION -- APPENDICES -- REFERENCES -- Chapter 2 AIDS: A MUCOSAL APPROACH TO A MUCOSAL INFECTION -- ABSTRACT -- INTRODUCTION -- Mucosal Transmission and HIV Receptors -- Correlates of Protection -- LTNPs, Elite Controllers and Natural Hosts -- TARGETING THE MUCOSAL IMMUNE SYSTEM -- Mucosal Adjuvants -- Innate Immunity and Antiviral Factors -- Early Experiments Revisited - Xeno and Allo-Immunity in HIV Protection -- SUMMARY -- REFERENCES. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter 3 TRANSMISSION OF HIV FROM DENDRITIC CELLS TO CD4+ T CELLS: A PROMISING TARGET FOR VACCINATION AND THERAPEUTIC INTERVENTION -- ABSTRACT -- INTRODUCTION -- 1. Subsets of DCs and Susceptibility to HIV Infection -- 2. Restriction of HIV-1 Replication in DCs -- 3. HIV Transmission from DC to T cells: trans vs. cis Infection -- 4. How to Achieve Immune Protection: Future Directions -- CONCLUSION -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 4 THE GLOBALIZATION-AIDS-POVERTY SYNDROME IN AFRICA1 -- INTRODUCTION -- NEOLIBERALIZM AND AIDS IN CONTEXT -- COLONIALISM, GENDER, AND THE GEOGRAPHY OF HIV -- THE LIBERALIZATION OF AIDS: GLOBALIZATION AND POVERTY -- MAKING THE LINKS: GENDER, DEEPENING POVERTY AND AIDS -- BREAKING THE GAPS -- REFERENCES -- Chapter 5 YOUTH SEXUALITY IN THE CONTEXT OF HIV/AIDS IN SOUTH AFRICA -- ABSTRACT -- 1. INTRODUCTION -- Socialization -- Sexual Relations -- Sexuality Research and HIV -- Culture and Sexuality -- Sociohistorical Context -- 2. METHODOLOGY -- Sample and Procedure -- Measure -- Definitions -- 3. STEADY RELATIONSHIPS -- Context of Steady Relationships -- Family -- Meaning of Steady Relationship -- Happy Experience in Steady Relationship -- Unhappy Experience in Steady Relationship -- Emotional Involvement in Steady Relationships -- Sexuality in Steady Relationships -- Separations -- Youth Without a Steady Partner -- 4. SEXUAL EXPERIENCES -- Type of Sexual Activity -- Age of Sexual Activity -- Frequency of Sexual Activity and Abstinence -- Worries and Fears of Age Mates in Regard to Partnership, Love and Sexuality -- 5. FIRST SEXUAL INTERCOURSE -- Partner Age Differential -- Type of Relationship -- Reasons for First Sexual Intercourse -- Experience of First Sexual Intercourse -- Contraceptives for First Sexual Intercourse -- 6. SEXUAL ATTITUDES -- Love and Sexuality. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Sexual Differences Regarding Sexual Desire -- Sexual Orientation -- Masturbation -- Sexual Experiences Not Discussed -- 7. MENSTRUATION, PREGNANCY, AND ABORTION -- Menstruation -- Pregnancy -- Fear of Being Pregnant -- Father of Pregnancy -- Reasons for Reactions to Possible Pregnancy -- Abortion -- 8. SEXUAL HARASSMENT AND VIOLENCE -- Boy's Experiences of Sexual Harassment -- Girl's Experiences of Sexual Harassment -- Violence -- 9. HIV/AIDS -- Epidemiology -- Sexual Experiences -- HIV Risk Perception and Behavior -- HIV Prevention -- 10. TOBACCO AND SUBSTANCE USE -- 11. SOCIOECONOMIC DIFFERENCES -- Socioeconomic Sample Characteristics -- Geolocality and Education of Youth -- Education/Occupation of Parents -- Religion and Religious Involvement -- 12. PEER PERCEPTIONS ON SEX AND RELATIONSHIP -- 13. CONCLUSIONS -- Urban-Rural Differences -- Socioeconomic Differences -- Sexuality Education -- REFERENCES -- Chapter 6 VITAMIN E IN THE CONTEXT OF HIV DISEASE: CURRENT KNOWLEDGE AND PERSPECTIVES -- ABSTRACT -- ABBREVIATIONS -- 1. INTRODUCTION -- 2. VITAMIN E IN HIV INFECTED PERSONS -- 3. INCREASED LEVELS OF ROS AND APOPTOSIS: COULD VITAMIN E INCREASE CELLULAR VIABILITY? -- 4. VITAMIN E AND ALTERED EXPRESSION OF CCR5 HIV CORECEPTOR -- 5. VITAMIN E AND HAART -- 5.1 Could Vitamin E Decreases HAART Toxity? -- 5.2 Dislipidemia and Vitamin E -- 5.3 Drug-to-drug Interactions via Pregnane X Receptor -- 6. CONCLUSION AND PERSPECTIVES -- REFERENCES -- Chapter 7 CCR5 GENE EXPRESSION AND POLYMORPHISM AS POTENTIAL PROGNOSTIC MARKERS OF THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION -- ABSTRACT -- INTRODUCTION -- CC CHEMOKINE RECEPTOR 5 (CCR5) -- CCR5 DELETION MUTATION -- CCR5 IN EBV INFECTION -- CCR5Δ32 POLYMORPHISM AND EBV REACTIVATION IN PATIENTS AFTER ALLOGENEIC HSCT -- CCR5 IN GRAFT-VERSUS-HOST DISEASE. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | CCR5Δ32 POLYMORPHISM AND THE RISK OF GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HSCT -- GENERAL SUMMARY AND CONCLUSIONS -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 8 EMERGING ROLES OF SDF-1α -CXCR4 AXIS IN VERTEBRATE DEVELOPMENT -- ABSTRACT -- INTRODUCTION -- Migration of Primary Germ Cells -- Migration of the Lateral Line Primordium -- Migration of Neural Cells Regulated by SDF-1α - CXCR4 -- Cell Determination/Differentiation Requires Cxcr4-Sdf1 Signaling -- ACKNOWLEDGEMENT -- REFERENCES -- INDEX. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | AIDS vaccines. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV (Viruses). |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Kendow, Lawrence B. |
| Title | AIDS Vaccines, HIV Receptors, and AIDS Research |
| Place, publisher, and date of publication | New York : Nova Science Publishers, Incorporated,c2008 |
| International Standard Book Number | 9781606920749 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018307">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018307</a> |
| Public note | Click to View |
No items available.